Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate-propofol ratio study in laparoscopic gynecologic surgery
ChiCTR2000039314Phase 4Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of etomidate and propofol (4 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: sleep duration. Started Jan 2019; status: completed.
02
Drugs
etomidatepropofol
Beyond the preview
Go deeper on ChiCTR2000039314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039314.